Cognitive and clinical outcome measures for Alzheimer's disease prevention trials in adults with Down syndrome The conduct of clinical investigations in the Down syndrome population (2020)

First Author: Strydom A

Attributed to: LonDownsPREVENT: A longitudinal study of the mechanisms of cerebral amyloid angiopathy and neurodegeneration in Down syndrome to inform AD prevention funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/alz.043478

Publication URI: http://dx.doi.org/10.1002/alz.043478

Type: Journal Article/Review

Parent Publication: Alzheimer's & Dementia

Issue: S9